Peering Into Structure Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Structure Therapeutics (NYSE:GPCR) has seen a 31.9% increase in short interest, with 19.35% of its float sold short. This is higher than the peer group average of 12.30%. It would take traders 8.48 days to cover their short positions.
July 15, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Structure Therapeutics (NYSE:GPCR) has experienced a significant increase in short interest, now at 19.35% of its float. This is notably higher than its peers' average of 12.30%. The elevated short interest could indicate bearish sentiment but also presents a potential for a short squeeze.
The significant increase in short interest suggests that investors are bearish on GPCR. However, the high short interest also means there is potential for a short squeeze if the stock price rises, forcing short sellers to cover their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100